Eva Brand

8.6k total citations
142 papers, 4.1k citations indexed

About

Eva Brand is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Brand has authored 142 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Physiology, 35 papers in Molecular Biology and 35 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Brand's work include Lysosomal Storage Disorders Research (55 papers), Hormonal Regulation and Hypertension (29 papers) and Trypanosoma species research and implications (28 papers). Eva Brand is often cited by papers focused on Lysosomal Storage Disorders Research (55 papers), Hormonal Regulation and Hypertension (29 papers) and Trypanosoma species research and implications (28 papers). Eva Brand collaborates with scholars based in Germany, United States and United Kingdom. Eva Brand's co-authors include Malte Lenders, Jan A. Staessen, Boris Schmitz, Stefan-Martin Herrmann, Stefan‐Martin Brand, Florent Soubrier, Ji‐Guang Wang, Thomas Duning, Giuseppe Bianchi and Nathalie Chatelain and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

In The Last Decade

Eva Brand

138 papers receiving 4.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eva Brand 1.4k 1.3k 1.1k 1.0k 676 142 4.1k
Adam R. Wende 2.6k 1.9× 1.5k 1.2× 485 0.5× 3.3k 3.3× 675 1.0× 85 5.8k
Johannes‐Peter Stasch 2.7k 1.9× 2.3k 1.9× 454 0.4× 1.9k 1.9× 173 0.3× 143 5.6k
Andrew W. Norris 1.7k 1.2× 389 0.3× 467 0.4× 1.6k 1.6× 967 1.4× 73 4.0k
Pawel M. Kaminski 2.4k 1.7× 1.3k 1.0× 334 0.3× 1.5k 1.5× 263 0.4× 68 4.9k
Éric Thorin 1.4k 1.0× 1.7k 1.4× 308 0.3× 1.3k 1.3× 319 0.5× 157 4.5k
Lin Chang 1.6k 1.1× 1.4k 1.1× 330 0.3× 1.2k 1.2× 853 1.3× 98 5.0k
Chaoshu Tang 1.6k 1.2× 933 0.7× 289 0.3× 1.4k 1.4× 560 0.8× 126 5.3k
Tetsuro Ago 1.6k 1.2× 1.1k 0.9× 348 0.3× 2.7k 2.7× 1.4k 2.1× 169 7.3k
Malcolm Lewis 2.9k 2.1× 2.5k 2.0× 719 0.7× 1.1k 1.1× 259 0.4× 114 6.8k
Georg Kojda 2.1k 1.5× 1.6k 1.3× 317 0.3× 1.1k 1.1× 176 0.3× 108 4.8k

Countries citing papers authored by Eva Brand

Since Specialization
Citations

This map shows the geographic impact of Eva Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Brand more than expected).

Fields of papers citing papers by Eva Brand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Brand. The network helps show where Eva Brand may publish in the future.

Co-authorship network of co-authors of Eva Brand

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Brand. A scholar is included among the top collaborators of Eva Brand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Brand. Eva Brand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brand, Eva, Aleš Linhart, Patrick Deegan, et al.. (2025). Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 20(1). 7–7. 5 indexed citations
2.
Lenders, Malte, Albina Nowak, Markus Cybulla, et al.. (2025). Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease. Orphanet Journal of Rare Diseases. 20(1). 79–79. 4 indexed citations
3.
Lenders, Malte, et al.. (2025). Progress and Challenges in the Treatment of Fabry Disease. BioDrugs. 39(4). 517–535. 2 indexed citations
4.
Lenders, Malte, Albina Nowak, Markus Cybulla, et al.. (2024). Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease. Orphanet Journal of Rare Diseases. 19(1). 490–490. 4 indexed citations
5.
Hughes, Derralynn, Gere Sunder‐Plassmann, Ana Jovanović, et al.. (2024). Renal and multisystem effectiveness of 3.9 years of migalastat in a global real‐world cohort: Results from the followME Fabry Pathfinders registry. Journal of Inherited Metabolic Disease. 48(1). e12771–e12771. 7 indexed citations
6.
Lenders, Malte, et al.. (2024). Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease. BioDrugs. 39(1). 153–165. 2 indexed citations
7.
Lenders, Malte, et al.. (2024). Biochemical Amenability in Fabry Patients Under Chaperone Therapy—How and When to Test?. BioDrugs. 38(6). 845–854. 1 indexed citations
8.
Lenders, Malte, et al.. (2023). Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease. Frontiers in Immunology. 14. 1266082–1266082. 6 indexed citations
9.
Jehn, U., Veerle Van Marck, Thomas Weide, et al.. (2021). α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes. International Journal of Molecular Sciences. 22(21). 11339–11339. 19 indexed citations
10.
Wanner, Christoph, Ulla Feldt‐Rasmussen, Ana Jovanović, et al.. (2020). Cardiomyopathy and Kidney Function in Agalsidase Beta-Treated Female Fabry Patients: A Pre-Treatment vs. Post-Treatment Analysis. ESC Heart Failure. 7(3). 825–834. 21 indexed citations
11.
Lenders, Malte, et al.. (2020). In Vitro and In Vivo Amenability to Migalastat in Fabry Disease. Molecular Therapy — Methods & Clinical Development. 19. 24–34. 31 indexed citations
12.
Germain, Dominique P., Eva Brand, Alessandro P. Burlina, et al.. (2018). Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study. Molecular Genetics & Genomic Medicine. 6(4). 492–503. 81 indexed citations
13.
Brand, Eva, et al.. (2018). Importance of the cultivation history for the response of Escherichia coli to oscillations in scale-down experiments. Bioprocess and Biosystems Engineering. 41(9). 1305–1313. 13 indexed citations
14.
Schmitz, Boris, et al.. (2018). ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA. Scientific Reports. 8(1). 4230–4230. 4 indexed citations
15.
Engelbertz, Christiane, Holger Reinecke, Günter Breithardt, et al.. (2017). Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry. International Journal of Cardiology. 243. 65–72. 19 indexed citations
16.
Schmitz, Boris, Stefan‐Martin Brand, & Eva Brand. (2014). Aldosterone signaling and soluble adenylyl cyclase—A nexus for the kidney and vascular endothelium. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(12). 2601–2609. 11 indexed citations
17.
Engelen, Markus A., Eva Brand, Thorsten Marquardt, et al.. (2012). Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Münster Study (FaMüS) data. BMJ Open. 2(6). bmjopen–2012. 11 indexed citations
18.
Brand, Eva. (2003). Children's beliefs about learning: structures and strategies. Bulletin of the Council for Research in Music Education. 9–17. 3 indexed citations
19.
Brand, Eva. (2000). Bridging the Gap Between Research and Teaching. Bulletin of the Council for Research in Music Education. 3(147). 30–35.
20.
Brand, Eva. (1998). The Process of Identifying Children's Mental Model of Their Own Learning as Inferred from Learning a Song.. Bulletin of the Council for Research in Music Education. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam R. Wende Breakdown of academic impact, for papers by Johannes‐Peter Stasch Breakdown of academic impact, for papers by Andrew W. Norris Breakdown of academic impact, for papers by Pawel M. Kaminski Breakdown of academic impact, for papers by Éric Thorin Breakdown of academic impact, for papers by Lin Chang Breakdown of academic impact, for papers by Chaoshu Tang Breakdown of academic impact, for papers by Tetsuro Ago Breakdown of academic impact, for papers by Malcolm Lewis Breakdown of academic impact, for papers by Georg Kojda
Rankless by CCL
2026